PDS Biotechnology (PDSB) Interest & Investment Income (2014 - 2026)
PDS Biotechnology (PDSB) reported Interest & Investment Income of $125,405 for Q2 2026, down 62.4% from $333,624 a year earlier.
Powered by 
Analysis
PDS Biotechnology (PDSB) Interest & Investment Income (2014 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, PDS Biotechnology's Interest & Investment Income came in at $964,797, down 48.7% year-over-year; for FY2025, it came in at $1.22 million, down 51.6% from FY2024.
- Interest & Investment Income has a five-year compound annual growth rate of 85.8% (FY2020 to FY2025).
- By year, Interest & Investment Income came in at $2.51 million in FY2024 (-13.4%), $2.9 million in FY2023 (+210.4%), $935,180 in FY2022 and $4,346 in FY2021 (-92.1%).
- The Q2 2026 figure ranks as the lowest quarterly Interest & Investment Income since Q2 2022.
- The high point for year-over-year Interest & Investment Income in five years was Q2 2023 (growth of 907.0%); the low point was Q2 2026 (a decline of 62.4%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 219.00 Mn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | - |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 80.00 Mn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | - |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | - |
| 10 | PDS Biotechnology | 41.94 Mn | 41.94 Mn | - | 125,405.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 125,405.00 |
| Dec 31, 2025 | 224,659.00 |
| Sep 30, 2025 | 281,109.00 |
| Jun 30, 2025 | 333,624.00 |
| Mar 31, 2025 | 377,849.00 |
| Dec 31, 2024 | 503,942.00 |
| Sep 30, 2024 | 666,770.00 |
| Jun 30, 2024 | 675,209.00 |
| Mar 31, 2024 | 668,895.00 |
| Dec 31, 2023 | 683,540.00 |
| Sep 30, 2023 | 739,404.00 |
| Jun 30, 2023 | 750,654.00 |
| Mar 31, 2023 | 729,341.00 |
| Dec 31, 2022 | 602,862.00 |
| Sep 30, 2022 | 252,073.00 |
| Jun 30, 2022 | 74,547.00 |
| Mar 31, 2022 | 5,700.00 |
| Dec 31, 2021 | 1,729.00 |
| Sep 30, 2021 | 1,358.00 |
| Jun 30, 2021 | 604.00 |
API Access
PDS Biotechnology Interest & Investment Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=PDSB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "interest-and-investment-income", "ticker": "PDSB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=PDSB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();